Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia (QUALI)

Institut de Cancérologie de la Loire

Status: Terminated

Conditions: Metastatic Neoplasia; Systemic Treatment; Elderly Patients

Treatments: Other: geriatric intervention

Study type: Observational

Funder types: Other

Identifiers

NCT03743961

2018-0801

2018-A02315-50 (Other Identifier)

Details and patient eligibility

About

The aim of this study is to describe the impact of : Geriatric intervention contribution on quality of life of elderly patients receiving systemic treatments for metastatic neoplasia

Full description

Elderly cancer incidence increases exponentially with advancing age. However, elderly patients are largely underrepresented in cancer treatment trials. The geriatric population presents particular physical, mental, psychological or social specificities that may condition the prognosis especially for patients with metastatic neoplasia. Recently, the measurement of quality of life (QoL) in aging population is being recognized as an important part of clinical decision. It is therefore essential to set up prospective studies to evaluate the impact of oncogeriatric practices on the quality of life of elderly patients with metastatic neoplasia. The main objective of this prospective study is to describe the contribution of geriatric intervention on quality of life for for elderly (> 75 years) with metastatic solid cancer receiving systemic treatment during the first 6 months of their therapeutic management.

Enrollment: 28 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with solid metastatic neoplasia
• 75 years old or more
• Men or women
• ECOG between 0 and 3
• Patient receiving systemic antineoplasic treatment (chemotherapy, hormonotherapy, immunotherapy, targeted therapy)

Exclusion criteria

• ECOG 4
• Localized cancer
• Patients already included in a study witch could modify quality of life
• Patient unable to give their consent

Trial design

28 participants in 2 patient groups

Group A : control group

Description:

Evaluation of quality of life with the EORTC QoL ELD 14 (Quality Qf Life ELDerly patients with 14 Questions) and QoL EORTC Q30 (Quality Qf Life with 30 Questions) for patients with G8 score \> 14/17

Group B : geriatric intervention group

Description:

Evaluation of quality of life with the EORTC QoL ELD 14 (Quality Qf Life ELDerly patients) and QoL (Quality Qf Life) EORTC Q30 for patients with G8 score ≤14/17 ( in this arm there is two groups : patient who received geriatric intervention before treatment initiation (group A) and group of patient did not received geriatric intervention before treatment initiation( group B))

Treatment:

Other: geriatric intervention